E. Schiffrin

Cardiology and Cardiovascular Medicine · 2000–2015

A researcher in the Science corpus: 11 papers; trusts 7 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

• Cardiology and Cardiovascular Medicine — 219 citations into it; #424 of 906 by trust here, #242 by citations
• Physiology — 50 citations into it; #1,306 of 2,276 by trust here, #1,004 by citations
• Molecular Biology — 27 citations into it
• Immunology — 26 citations into it
• Biochemistry — 13 citations into it
• Neurology — 8 citations into it

Whom E. Schiffrin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. K. Griendling
2. B. Lassègue
3. Rhian M. Touyz
4. R. Clempus
5. J. Lambeth
6. T. Guzik

Who trusts E. Schiffrin overall

1. Rhian M. Touyz
2. P. Mehta
3. M. Félétou

Papers from E. Schiffrin's perspective

Ordered by how strongly the researchers E. Schiffrin trusts endorse each paper. Same corpus, a different order for every researcher.

1. Angiotensin II Stimulation of NAD(P)H Oxidase Activity: Upstream Mediators (Circulation Research)
2. The neutrophil NADPH oxidase. (Archives of Biochemistry and Biophysics)
3. NAD(P)H oxidase: role in cardiovascular biology and disease. (Circulation Research)
4. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. (Free Radical Biology & Medicine)
5. Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase (Circulation)
6. Voltage-dependent Anion Channels Control the Release of the Superoxide Anion from Mitochondria to Cytosol* (Journal of Biological Chemistry)
7. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism (Cellular and Molecular Life Sciences (CMLS))
8. Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II (Circulation Research)
9. Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure (Circulation)
10. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. (HYPERTENSION)

Their papers

• Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. (2000) — 953 citations
• Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness (2015) — 1,246 citations
• The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013) — 618 citations
• The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. (2010) — 2,806 citations
• Chronic Kidney Disease: Effects on the Cardiovascular System (2007) — 1,501 citations
• Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. (2005) — 674 citations
• Endothelial dysfunction. (2004) — 700 citations
• Reactive oxygen species in vascular biology: implications in hypertension (2004) — 651 citations
• Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II (2002) — 616 citations
• Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis (2001) — 996 citations
• Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. (2000) — 638 citations